passages.id: split_5_test_3212_passage
passages.type: progene_text
passages.text: The binding rates of multivalent anti - prostate - cancer / anti - CD3 bispecific scFv with PBMC and PC-3 cells were 70.4 % and 81 % respectively , significantly higher than those of anti - prostate - cancer / anti - CD3 bispecific scFv .